Vaccines Receives an Updated Impact Factor of 3.4

We are pleased to share that Vaccines (ISSN: 2076-393X) was awarded an updated Impact Factor of 3.4 in the 2024 Journal Citation Reports™ released by Clarivate™ in June 2025. Vaccines ranks in Q2 (85 out of 183) in the “Immunology” category and Q2 (75 out of 195) in the “Medicine, Research and Experimental” category. Vaccines ranks in the first quartile (Q1) in these two JCI-indexed subject areas.

The 2024 Journal Impact Factor is calculated by dividing the number of citations received in 2024 to all publications in the journal from 2022 and 2023 by the total number of citable publications from those same years.

To learn more, visit our journal statistics website for detailed metrics or check out our news article for general information.

The support and dedication of all the editors, reviewers, authors, and readers are an integral part of the journal’s performance. We would like to take this opportunity to thank all of you who have contributed to the journal.